Ligand Pharmaceuticals Incorporated (LGND) Q1 2026 Earnings Call Transcript
Ligand Pharmaceuticals Inc LGND
$213.21
▼ -2.63%
($-5.77)
Open
$216.66
Prev Close
$218.98
Day Range
$212.70 – $218.13
52W Range
$98.89 – $247.38
Market Cap
$4.27B
P/E (TTM)
34.33
Beta
1.53
EPS (TTM)
$5.88
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1992-11-18 |
| Shares Out. | 19,940,000 |
| Website | ligand.com/ ↗ |
| Phone | 13026365401 |
Ligand Pharmaceuticals Inc is a publicly traded company under the ticker symbol LGND on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-05-01)
📰 Latest News for LGND
Transcript : Ligand Pharmaceuticals Incorporated, Q1 2026 Earnings Call, May 07, 2026
Ligand Pharmaceuticals Incorporated 2026 Q1 - Results - Earnings Call Presentation
RBC Capital Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $262
Ligand Pharmaceuticals Q1 Earnings Call Highlights
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss
Ligand Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2026
Ligand Reports First Quarter 2026 Financial Results